Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that today the University of Oxford MRC Brain Network Dynamics Unit joins the Nuffield Department of Clinical Neurosciences (NDCN) as a sixth division.

Large group of people on steps of building

The MRC BNDU had its funding renewed earlier this year, and is developing its integrated approach to fundamental and translational neuroscience. NDCN as its new host department will be able to exploit existing collaborations with MRC BNDU researchers, as well as finding new ways to work together.

The MRC BNDU’s key strength is its focus on understanding and exploiting the moment-to-moment interactions between brain cells, particularly those involved in movement and memory. A deeper understanding of these circuits could help us develop interventions for when things go wrong in these brain mechanisms.

We in NDCN look forward to learning from the MRC BNDU’s exemplary approach to public engagement, staff development, data sharing and working with industry.

The Unit, led by Professor Peter Brown, will continue to have its main physical base next to the Department of Pharmacology on Mansfield Road. This will help to consolidate our foothold ‘down the hill’, first established by our Sleep and Circadian Neuroscience Institute, which is currently located in the Dunn School of Pathology.

Find out more at www.mrcbndu.ox.ac.uk/

Similar stories

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

COVID-19 infection has greater risk than vaccines of causing very rare neurological events

Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.